We recently attended a pharmacovigilance and regulatory conference which is organised annually by European stakeholder association Medicines for Europe whose member is also Billev Pharma East d.o.o.. The conference was attended not only by a large number of industry representatives, but also by many representatives of the national competent authorities from different European countries and European Medicines Agency, with opportunity for a comprehensive discussion about the current issues pharma world is facing and finding »win-win« solutions.
